Speakers: Jim Krenn, Shai Kalansky, and Alex Okuliar
- Our in-depth legal webinar continues as we explore the dynamic landscape of venture financing and mergers & acquisitions (M&A) in the biologics sector, with a special focus on cell and gene therapies. As these innovative treatments continue to transform patient care, understanding the financial and regulatory frameworks is crucial for legal professionals, investors, and biotech companies. This presentation will provide valuable insight, including insight into:
- Overview of funding for cell and gene therapy companies, such as analysis of recent investment trends and deal structures and terms, among other key criteria.
- M&A Landscape in Biologics, such as deal activity, legal and antitrust considerations and challenges in negotiating deals, and emerging opportunities and potential pitfalls.
RSVP here
